Trials / Conditions / Ulcerative Colitis Chronic Moderate

Ulcerative Colitis Chronic Moderate

14 registered clinical trials studyying Ulcerative Colitis Chronic Moderate — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study of Novel Therapeutics for Acute Remedy of Colitis NCT06420492	Brigham and Women's Hospital	Phase 2
Recruiting	Combination of Diet and Oral Budesonide for Ulcerative Colitis NCT05791487	Wolfson Medical Center	N/A
Recruiting	Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis NCT06311123	University of California, San Diego	—
Unknown	Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal Ulcers NCT05912712	Xijing Hospital of Digestive Diseases	Phase 1
Recruiting	R-3750 in Patients With Mild to Moderate Ulcerative Colitis NCT05666960	Rise Therapeutics LLC	Phase 1
Unknown	Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerat NCT05735665	IRCCS San Raffaele	N/A
Completed	Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease NCT05194007	Mohammed Bin Rashid University of Medicine and Health Sciences	Phase 2 / Phase 3
Completed	Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis NCT04353791	Oncostellae S.L	Phase 1 / Phase 2
Completed	PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC) NCT04504383	Protagonist Therapeutics, Inc.	Phase 2
Completed	Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients NCT04102852	San Giovanni Addolorata Hospital	Phase 1 / Phase 2
Terminated	ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis NCT03923478	Assembly Biosciences	Phase 1
Unknown	The Safety and Efficacy of TET Enema in the Treatment of UC NCT03917095	The Second Hospital of Nanjing Medical University	N/A
Unknown	Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately A NCT03716388	Dayanand Medical College and Hospital	Phase 3
Completed	Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO) NCT03565939	ParaTech A/S	Phase 2